Edward Garon
MD
Professor of Medicine and Director, Thoracic Oncology Program
👥Biography 个人简介
Dr. Edward Garon is a thoracic oncologist who was a key investigator in the KEYNOTE-407 trial that established pembrolizumab plus chemotherapy as first-line therapy for metastatic squamous NSCLC. He also contributed to KEYNOTE-024 for high PD-L1 expressors and has been active in multiple pembrolizumab-based trials. His research focuses on biomarker-driven selection of immunotherapy in lung cancer.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Edward Garon 的研究动态
Follow Edward Garon's research updates
留下邮箱，当我们发布与 Edward Garon（UCLA Jonsson Comprehensive Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment